IGI Laboratories Announces First Quarter 2015 Results

Go back to IGI Laboratories Announces First Quarter 2015 Results

Oppenheimer Downgrades IGI Laboratories (IG) to Perform

April 29, 2015 7:51 AM EDT

Oppenheimer downgraded IGI Laboratories (NYSE: IG) from Outperform to Perform and removed its price target (prior $12.00).

For an analyst ratings summary and ratings history on IGI Laboratories click here. For more ratings news on IGI Laboratories click here.

Shares of IGI Laboratories closed at $7.95 yesterday.

... More

IGI Labs (IG) Misses Q1 EPS by 1c, Q2 Revenue Guidance Falls Short

April 28, 2015 4:42 PM EDT

IGI Labs (NYSE: IG) reported Q1 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $10.7 million versus the consensus estimate of $12.32 million.

IGI's President and Chief Executive Officer, Jason Grenfell-Gardner, stated, "Consistent with our expectations, based on... More